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A 24-year-old  woman  was  referred  at  35  weeks’  gestation,  after  ultrasound  diagnosis  of  a
fetal  tumour  near  the  kidney.  Ultrasound  showed  a  6  cm  tissular  mass,  heterogeneous  and
hypervascular,  developed  from  the  upper  pole  of  the  left  kidney  or  adrenal  gland  (Fig.  1a).
The  diagnoses  discussed  were  neuroblastoma  (NB),  adrenal  hematoma,  kidney  tumour,
and  subdiaphragmatic  bronchopulmonary  sequestration.  Magnetic  resonance  Imaging
(MRI)  conﬁrmed  the  tissular  nature  and  exorenal  location,  coinciding  with  the  midline  and
displacing  retroperitoneal  vessels  (Fig.  1b).  Its  signal  was  heterogeneous,  hyperintense
in  T2.  No  other  lesion  was  found.  The  patient  was  informed  of  the  likely  adrenal  origin
and  the  difﬁculty  of  exclusionary  formal  differential  diagnoses  before  birth.  Ultrasound
at  37  weeks’  gestation  found  a  slight  increase  in  size.  Moreover,  a  polyhydramnios
appeared  with  cardiomegaly,  dilated  right  atrium  and  a slight  tricuspid  regurgitation
(60  cm/sec),  an  increase  of  maximum  velocity  of  the  middle  cerebral  artery  (Vmax  MCA)
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Figure 1. a: axial ultrasonographic view of the fetal abdomen at 37 weeks’ showing a large heterogenous suprarenal mass; b: axial
view at the middle of the abdomen using T2-weighted HASTE sequences showing a large tumor above and in front of the kydney with an
intermediate signal and well limited; c: axial view using T2-weighted HASTE sequences at the level of the ‘‘four cavities view’’ showing
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invasion.  Placenta  did  not  show  metastasis.  In  summary,  itan intraparenchymatous pulmonary left secondary lesion; d: thora
formations considered as metastases.
corresponding  to  1.74  MoM.  Anaemia  due  to  bleeding,
haemolysis  within  the  tumour  or  high  cardiac  output  fail-
ure  could  explain  these  signs.  Amniodrainage  was  decided
because  of  dyspnea  and  poor  maternal  hemodynamic  toler-
ance,  then  a  caesarean  section  was  decided.  A  3,060-g  girl
was  born.  Her  status  deteriorated  rapidly.  She  was  intubated
and  transfused,  given  a  12  g/dL  moderate  anaemia.  Urinary
catecholamines  were  signiﬁcantly  increased,  noradrenalin
particularly.  A  thoracic  and  abdominopelvic  computed
tomography  (CT)  scan  carried  out  at  24  hours  of  life  found  a
7.7  cm  left  retroperitoneal  tissular  lesion,  characterized  by
a  spontaneous  hypodensity  with  some  punctuate  calciﬁca-
tions,  enhancing  heterogeneously  with  contrast  media  and
without  macro-systemic  vascularisation.  There  was  a fatty
peripheral  cleavage  plane  with  the  aorta,  and  a  26  mm  tis-
sular  mass  on  the  contralateral  adrenal  gland  which  was  not
seen  on  prenatal  imaging  and  had  probably  increased  since
then.  In  the  liver  was  a  hypodense  macronodular  formation;
its  metastatic  nature  was  supported  by  targeted  ultrasound
w
n
tomputed tomography (CT) showed several intrapulmonar nodular
howing  multiple  hyperechoic  liver  nodules,  revealing  Pep-
er  Syndrome.  In  addition,  thoracic  CT  showed  several
ntrapulmonary  nodular  formations  (Fig.  1c)  also  suggesting
etastases.  Looking  back  at  the  fetal  MRI,  it  was  clear  that
t  least  one  pulmonary  metastasis  was  present  (Fig.  1d),  but
o  liver  metastases  could  be  retrospectively  visualized.  A
eta-iodobenzylguanidine  scintography  (MIBG)  uptake  test
howed  a  right  adrenal  region  and  left  hepatic  uniform  ﬁxa-
ion,  reinforcing  the  external  part  of  the  left  lung,  and  a  very
uspicious  skull  mass.  A  surgical  ‘‘debulking’’  to  minimise
he  tumour  and  try  to  control  hemodynamics  was  performed.
 laparotomy  enabled  resection  of  a  retroperitoneal  encap-
ulated  intra-adrenal  tumour  weighing  192  g.  It  was  a  poorly
ifferentiated  NB  with  unfavourable  mitotic  index.  A  myel-
gram  performed  on  a  tibial  crest  also  showed  metastaticas  an  adrenal  secreting  NB  stage  IV  according  to  the  Inter-
ational  Neuroblastoma  Staging  System  (INSS).  The  patient
hen  received  two  courses  of  chemotherapy.  A  whole  body
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RI  control  at  4  months  showed  an  absence  of  signal  abnor-
ality  in  the  right  adrenal  area,  and  a  stable  left  adrenal
esion.  There  was  a  regression  of  the  left  parietal  lesion  in
he  number  and  size  of  the  hepatic  lesions,  and  the  left
asal  pulmonary  lesion  had  disappeared.  Two  new  courses
f  chemotherapy  are  planned.
NB  is  a  tumor  arising  from  the  sympathetic  embryonic
issue.  It  is  the  most  common  solid  cancer  of  early  child-
ood.  About  93%  of  NBs  are  located  at  the  adrenal  gland.
renatal  diagnosis  of  adrenal  NB  takes  place  often  after  32
eeks’  gestation,  although  it  has  been  described  as  early
s  22  weeks.  It  is  classically  right  suprarenal  (60%),  appears
ystic  in  50%  of  cases  if  not  solid  or  mixed.  Calciﬁcations
re  less  common  than  in  the  pediatric  population  where
hey  are  classic  [1].  Differential  sonographic  diagnoses
f  the  suprarenal  NB,  whether  tissular,  cystic,  or  mixed,
re  adrenal  haemorrhage,  extralobar  subdiaphragmatic  pul-
onary  sequestration  (ESPS),  mesoblastic  nephroma  and
drenal  carcinoma.  Only  50%  of  suprarenal  masses  are  NB.
ne  must  therefore  be  cautious  when  establishing  this  diag-
osis  [2].  Many  elements  of  our  observation  favoured  ESPS.
lassically  on  the  left  (90%),  it  is  almost  exclusively  tis-
ular.  In  our  case,  there  was  no  arterial  supply  from  the
orta,  but  the  tumour  was  highly  vascular,  which  is  not
ypical  of  NB.  The  systemic  vasculature  of  an  ESPS  can  be
nderdiagnosed  with  ultrasound  and  prenatal  MRI  [3].  ESPS
an  be  classically  complicated  with  hemodynamic  failure,
hich  could  explain  the  discrepancy  between  moderate  ane-
ia  and  severe  hemodynamic  failure,  which  was  actually
aused  by  a  massive  tumoral  secretion  of  catecholamines.
inally,  classical  forms  of  ESPS  change  little  in  size,  while
B  can  grow  rapidly,  which  allows  for  its  diagnosis  in  the
hird  trimester  [4].  In  our  case,  the  increase  in  size  was
mall  and  not  very  discriminative.  In  order  to  precise  the
iagnosis,  a  test  for  homovanillic  acid  in  the  amniotic
uid  could  be  carried  out.  However,  a  literature  review
y  Acharya  et  al.  of  55  cases  showed  that  about  65%  of
iagnosed  prenatal  NB  are  non-secretant  [5].  This  method
eems  nevertheless  underutilised,  as  the  assay  appears  to
e  speciﬁc  [6].  Invasive  sampling  will  therefore  be  per-
ormed  if  its  result  inﬂuences  monitoring  or  taking  further
ction.
Once  the  diagnosis  is  strongly  suspected,  one  must  know
ow  to  use  all  the  tools  to  reﬁne  the  prognostic  evalu-
tion.  Indeed,  prognosis  is  very  variable,  and  guided  by
everal  criteria.  Cystic  appearance  is  associated  with  a
istological  appearance  consistent  with  involution:  small
ggregates  of  neuroblasts  in  the  cyst  wall  (suggestive  of
n  situ  NB),  rather  than  sheets  of  tumour  cells  (encoun-
ered  with  invasive  NB).  Actually,  these  cystic  NBs  often
ave  favourable  biological  markers  and  are  less  often  sec-
etant  [1].  It  appears  therefore  that  the  cystic  nature  of
he  tumour  may  be  a  favourable  prognostic  factor.  Postnatal
onitoring  strategies  are  proposed  at  birth  with  a  non-
egligible  probability  of  spontaneous  regression,  especially
or  asymptomatic  cystic  NB,  with  a  good  prognosis  without
iological  and  remote  extension  [7,8]. Surgical  indications
an  certainly  be  considered  if  size  increase  occurs.  The  stage
f  the  INSS  classiﬁcation  seems  to  be  the  major  prognosis
[N.  Menager  et  al.
actor.  The  preferred  metastatic  site  is  the  liver  (approx-
mately  25%  of  patients  according  to  Acharya),  but  it  has
een  shown  that  prenatal  ultrasound  detection  is  difﬁcult
nd  can  perhaps  be  caught  by  fetal  MRI  [5].
Other  metastatic  sites  are  possible,  such  as  skin  or  bones.
RI  performed  at  35  weeks’  gestation,  after  analysis  of
ostnatal  CT  scan,  indicates  that  at  least  one  pulmonary
etastasis  was  visible,  which  had  not  yet  been  described
n  the  literature;  we  must  therefore  search  for  it  more
peciﬁcally  in  the  future.  One  may  also  develop  dedicated
RI  sequences  for  bone  metastases  or  propose  a  fetal  CT
can.
Our  case  demonstrates  the  need  to  closely  monitor
uspected  antenatal  NB,  the  maximum  interval  between
wo  ultrasound  examinations  should  not  exceed  2  weeks.
renatal  diagnosis  of  NB  and  its  extent  allows  to  plan
he  birth  appropriately  and  to  better  inform  the  future
arents.  Prenatal  diagnosis  is  playing  an  increasing  role,  so
he  challenge  is  now  to  distinguish  between  localised  and
isseminated  forms.  MRI  helps  to  optimise  discrimination
nd  can  be  used  not  only  to  examine  hepatic  metastases,
ut  also  lungs  and  bones.
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